Metastatic Castration-Resistant Prostate Cancer with BRCA2 Mutation: the Challenge Incorporating PARP Inhibitors and Platinum in Treatment Sequencing
European Journal of Case Reports in Internal Medicine（2022）
Key words
metastatic prostate cancer,brca2 germline mutation,parp inhibitor,olaparib,carboplatin,brca2-mutated metastatic castration-resistant prostate cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined